Citations 1
Efficacy and Disability Outcomes of Fremanezumab in Patients With Prior OnabotulinumtoxinA Treatment Failure: Pooled Results of 3 Randomized, Double-blind, Placebo-controlled Phase 3 Studies (P3-2.004)
Ning, Xiaoping , Campos, Verena Ramirez, Barash, Steve, Krasenbaum, Lynda J., McAllister, Peter , VanderPluym, Juliana H.
Neurology | December 6, 2023 | Volume: 98 | Issue: 18_supplement | Pages: No page available
